Gilbert Technologies designs and develops medical devices to improve health care, patient care and that offers a better quality of life through innovative and disruptive sustainable health technologies.
The technology is applied in novel medical inhalation devices with market-leading lung deposition characteristics for pulmonary medicine administration for Cystic Fibrosis (CF), Asthma, Oncology (Lung cancer), Pulmonary Arterial Hypertension, as well as Non-CF Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, Transplantation, Pain management, Vaccination and other indications.
The patented technology is based on unique electro spraying technics (EHDA) developed by the Delft University of Technology. By owning the rights to the technology, Gilbert is entitled to exclusively and worldwide commercialize this technology.
|Participation since||June 2011|
|Founders||Frans van Leuven